Yang et al. (83) reported that an oral administration of curcumin, which is clinical valuable for the treatment of IBD (103), in DSS-treated rats could significantly ameliorate visceral hyperalgesia through inhibiting phosphorylation of TRPV1, indicating a nociceptive effect of TRPV1. Here, TRPV1 is linked to inflammatory bowel disease.